SYNDROME
Ferina MEGA SILVIA
1707101030131
Dr. Sri Murdiati, Sp.JP (K), FIHA
2
“
GBS in all world is around 1
to 2 from 100,000, Where
on variants MFS there on
partially small case (1 to 2
from 1,000,000).
3
CASE
REPORT
Identitas
pasien
Nama “
: Ny. I Q
Jenis Kelamin : Wanita
Usia : 32 Tahun
Alamat : Banda
‐ Aceh
Agama : Islam
Tanggal Masuk : 20/06/2019
Dikonsulkan : 24/06/2019
Rekam Medis : 1-18-60-03
5
“
Patient women 32 year consulted to part Cardiology from part neurology with
complaint chest flutter-debar and weak on all body that be perceived since
morning day, Patient already diagnosed with Millier Fisher syndrome,
initially patient come to IGD RSUDZA with complaint weak on second foot,
weak initially begins from sheath eye that difficult open so that patient appear
sleepy, then weaknesses happen on all body especially on hand and leg that
be accompanied with crowded breath, Patient too complain view hazy and
appear double. Fever, cold and painful head too already experienced patient
since some day before symptom appear,
6
hospital sheet ago
In October 2018 the patient do a
general checkup at a hospital in
Malaysia and was diagnosed with
GBS
8
VITAL SIGNS
Compos 49x/Menit
Mentis /
110/60 (regular, isi 20 x/ 36,8°C
mmHg cukup, kuat menit (Aksila)
GCS 15 angkat)
Physical examination
Ekstremitas
Leher Superior :Akral hangat (+/+),
Bentuk simetris, trakea lurus di Jantung edema (-/-), sianosis (-/-)
tengah, BJ I >BJ II, bising jantung (-) Inferior : Akral hangat (+/+), edema
Pembesaran KGB dan tiroid (-/-),sianosis (-/-)
10
Pemeriksaan FIsik
Paru Abdomen
11
Examination Neurologi
‐ GCS: E4M6V5
‐ Sign Excitatory meningeal : Rigid nape (-)
‐ nerve cranial : Pupil: Round, Isokor,
Paresis (-)
‐ motor : 5555/5555
3333/3333
urea 16 mg /dL
creatinine 0.60 mg /dL
GDS 113 mg /dL
SGOT 18 U / L
SGPT 30 U / L
CT Scan Head in February 2019
15
16
EKG
ECG interpretation (24.06.2019 o'clock 10:37 pm)
Diagnosa Tambahan:
Diagnosa Utama
Sinus Bradikardi
Sindrom Millier
Fisher Sindrom Cushing Syndrom
iatrogenik
20
Tatalaksana
Tatalaksana
Primary survey Airway : Tatalaksana kardiologi Tatalaksana Neurologi
Head Up300 Medikamentosa
Breathing : O2 Nasal Sulfas atrofin 1 amp/12jam iv. Methylprednisolon
kanul 2-4 L/menit Alprazolam 0,25 gr (k/p) 125mg/6 jam
Circulation : IVFD NaCl Ubi Q 1x 50mg Omeprazole 40 mg/
0,9% 20 gtt/menit Mydriatil (extra) 1gtt/hari 12jam
Sukralfat syr 15ml/8jam
21
follow Up
Daily
25/06/2019 26/06/2019 27/06/2019 28/06/2019
(H1) (H2) (H3) (H4)
Cardiology Cardiology Cardiology Cardiology
28
DEFINITION
syndrome Miller Fisher is abnormality neurologic I that be marked with presence trias manifes
tation clinical that is presence ataxia (lack of balance) ophthalmoplegia (paralysis muscle eye
) and areflexia (disappearance reflex tendon)
syndrome Miller Fisher described first time on 1956 by a doctor nationality Canada named Charles
Miller Fisher. syndrome this constitute circumstances I, rarely found, and considered as something
variants from syndrome Guillain Barre, syndrome Guillain Barre constitute polyneuropathy I, is
symmetrical and ascending,
Difference SGB and syndrome Miller Fisher that is on group nerve that struck, and paralysis that happe
n begins from leg, then up to the top, While that on syndrome Miller Fisher paralysis starts from head he
ad (on muscle eye) and then neck and arm,
29
ETIOLOGY
microorganisms cause not yet ever found on patient and not constitute
disease that spread too not downgraded in hereditary, Disease this constitute process autoim
mune,
But around half from all case happen after disease infection virus or bacterium as below this
:
• Infection virus : Citomegalovirus (CMV), Ebstein Barr Virus (EBV), enterovirusHuman
Immunodefficiency Virus (HIV).
• Infection bacterium : Campilobacter jejuni, Mycoplasma Pneumonie,
• Pascah surgery and vaccinations,
30
Pathophysiology
Role antibody antigangliosida GQ1b on pathogenesis syndrome Miller Fisher known on early year
1990. Anti GQ1b known related with level severity from syndrome Miller Fisher. syndrome MF related
with presence anti GQ1b on more from 80% patient,
31
CLINICAL
Ophthalmoplegia
Ataksia
Neuropati peripheral
32
GOVERNANCE
Observation
Immunoadsorption
33
bradycardia
34
DEFINITION
bradycardia relatively is beat heart more from 60 times /minute but still less from condition that should,
bradycardia will inflict problem when symptomatic or already inflict symptom result beat heart that too sl
ow
35
ETIOLOGY
1. disruption formation Impulse
Sine bradycardia
Factor intrinsic Extrinsic factors
Degeneration idiopathic (process aging) Impaired autonomic syndrome
infarction / ischemia syncope Neurokardial
Disease infiltrative Carotid Sinus Hypersensitivity
sarcoidosis Situational disturbance
amyloidosis Cough
haemochromatosis defecation
Collagen-Vascular Diseases BAK
SLE Gag
rheumatoid Arthritis Drug
scleroderma beta Blocker
Myotonic muscular dystrophy Calcium-channel blockers
trauma Surgery clonidine
Valve replacement digoxin
Correction of congenital disease antiarrhythmic drugs
heart transplant Hipothyroid
Heredity disease hypothermia
Infectious diseases Neurological Disorders
Chagas' Disease electrolyte Disorders
endocarditis hypokalemia
36 hiperkalemi
Sick Sinus Syndrome
(1) SInus bradycardia spontaneous that stay, which not caused by drug and not corresp
onding
with circumstances physiological;
(2) sinus arrest or exit block
(3) combination disruption conduction SA and AV
(4) bradycardia-tachycardia syndrome.
37
Hypersensitive Carotid Sinus Syndrome
hypersensitivity branch afferent or efferen from reflex arch sine carotid cause Activation
vagal and or inhibition sympathetic, so that cause bradycardia and vasodilation,
38
2. disruption penghantaran Impulse
AV Block level 1
AV Block level 2
• Block level 2 Type I
39
• Block level 2 type II
40
DISCUSSION
CASE DISCUSSION
43
CASE
“
‐
There relationship Miller Fisher syndrome with sine bradycardia
44
‐ complication cardiovascular rarely reported on Miller Fisher
syndrome however cause constitute disruption nerve
autonomous,
‐ Kuzumoto et al showing presence relationship between test
abnormality nerve autonomous and antibody anti-GQ1b on
patient MFS. complication not only limited on disruption
Respiratory weight but too condition that more light Where patient
not need help Respiratory and can walk more from 5 meters.
‐ Level damage nerve motor not could predict occurrence
bradyarythmia that serious including stopping sine. appraisal
early on Event that threaten soul as that very important for action
prevention that right, as insertion tool spur heart, can immediately
taken,
neuropathy autonomous constitute complication important syndrome
Guillain-Barre, visible on around 60% case and rarely happen MFS.
Case this often happen on person adult young with case that more
weight for mortality, disruption autonomous heart on GBS including
hypertension unstable, hypotension orthostatic, and various type
arrhythmias heart including sine tachycardia, serious bradyarrhythmia
and asistole, Manifestation this happen result disruption from lane nerve
sympathetic and parasympathetic,
dysfunction autonomous general happen on GBS and manifest as activity
that excessive or not adequate from activity tap heart ,abnormality tap heart
varies cause hypotension postural, sweat excessive, and hypertension,
event heart arrhythmias general happen on GBS. greenland and Griggs
record at least there arrhythmias on 13 from 16 patient that be learned ,
and they too find correlation that significant between dysfunction nerve
autonomous and atrioventricular block, implantation tool spur heart while
could do on patient because stopping sine.
A episode bradycardia sine spontaneous usually happen on day fifth
after appearance symptom neurologic with period stopping sine and
asystole for 15 second and usually responds with fast on massages
heart that could restore rhythm sine without drug What even. After
that period bradycardia and asystole could observed in intermittent
for suction endotracheal, atropine intravenous, 1 mg, could increase
beat heart, usually into 80 to 90 per minute, and decrease frequency
and duration period asystolic, Next, could be given infusion
isoproterenol continue constantly for keep tap heart 80 to 90 per
minute,
Installation from pacemaker while initially considered but because
danger infection, management medical use atropine and
isoproterenol be used for avoid manipulation intracardiac
transvenous, If not there is improvement in status neurologic after 8
Sunday occurrence bradycardia and asystole, demand intracardiac
permanent alath spur heart could programmed, After mounted tool
spur heart should often controlled even to 6 month after
implantation,
neuropathy autonomous is picture general and important that appear on
cardiovascular, sudomotor, gastrointestinal and system more involve nerve
parasympathetic and sympathetic, in special, activity excessive vagal could
cause bradaritmia serious start from bradycardia to asystole and constitute
cause total Dead that significant, in general believed that bradyarrhythmia
this happen only on patient with disease weight, especially on patient that
need ventilation mechanical, however, there is some case that explain
bradiartimia without ventilation mechanical and even on patient that not too
severe, picture dysrhythmias that potential threaten soul this very important
for start therapy prevention that right as tool spur heart external or monitoring
on unit care intensive (ICU).
THANK YOU
53